(Q56742295)

English

Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status

scientific article published in November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

refractory anemia

1 reference

based on heuristic

inferred from title

Refractory anemia with ring sideroblasts

1 reference

based on heuristic

inferred from title

Leonor Arenillas

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Gonzalo Gutiérrez-García

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Lourdes Florensa

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

J M Raya

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

A Domingo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

B Bellosillo

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

E Luño

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M A Piñán

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Barbón

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M L Pérez-Sirvent

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M J Muruzábal

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

L Yánez

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

L García

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

A Lemes

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

J T Navarro

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

A Elosegi

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M A Cortés

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

A Villegas

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M A Durán

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Ardanaz

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Grupo Español de Citología Hematológica (GECH), Working Group into the Asociación Española de Hematología y Hemoterapia (AEHH)

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

0 references

publication date

27 September 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

International Journal of Hematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

88

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

387-395

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

https://scigraph.springernature.com/pub.10.1007/s12185-008-0169-1

0 references

Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).

1 reference

https://api.crossref.org/works/10.1007%2FS12185-008-0169-1

21 January 2018

X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutation screening for JAK2V617F: when to order the test and how to interpret the results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the JAK2 V617F mutation is not found in de novo AML and MDS but is detected in MDS-derived leukemia of megakaryoblastic nature

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JAK2 in myeloproliferative disorders is not just another kinase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification, diagnosis and management of myeloproliferative disorders in the JAK2V617F era.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The JAK2 V617F mutation is rare in RARS but common in RARS-T

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease in older adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myelodysplastic/myeloproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18820995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-008-0169-1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18820995%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56742295&oldid=1586484909"